SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-051450
Filing Date
2014-08-19
Accepted
2014-08-19 17:28:53
Documents
5
Period of Report
2014-08-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v387098_8-k.htm 8-K 23076
2 EXHIBIT 1.1 v387098_ex1-1.htm EX-1.1 246066
3 EXHIBIT 99.1 v387098_ex99-1.htm EX-99.1 13970
4 EXHIBIT 99.2 v387098_ex99-2.htm EX-99.2 14050
5 GRAPHIC logo.jpg GRAPHIC 5911
  Complete submission text file 0001144204-14-051450.txt   306640
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35737 | Film No.: 141053100
SIC: 2834 Pharmaceutical Preparations